2012
DOI: 10.1007/s13181-012-0214-6
|View full text |Cite
|
Sign up to set email alerts
|

Open-Label Randomized Clinical Trial of Atropine Bolus Injection Versus Incremental Boluses Plus Infusion for Organophosphate Poisoning in Bangladesh

Abstract: Severe organophosphate compound (OPC) poisoning is an important clinical problem in many countries of the world. Unfortunately, little clinical research has been performed and little evidence exists with which to determine the best therapy. A study was therefore undertaken to determine the optimal dosing regimen for atropine in the

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
40
1
1

Year Published

2013
2013
2018
2018

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 59 publications
(45 citation statements)
references
References 23 publications
1
40
1
1
Order By: Relevance
“…Although the combination of a cholinesterase reactivator and anticholinergic atropine has a poor effect (Buckley et al, 2011;Elsinghorst et al, 2013), a previous study has shown that use of atropine at an optimum dose can decrease the mortality rate (Biswas et al, 2013). However, atropine has a short half-life, requires administration of large dosages, and patients with severe poisoning require intravenous administration (Abedin et al, 2012); moreover, repeated administration at an interval of 2-10 min is required (Connors et al, 2013) and nursing of patients is tedious; furthermore, an appropriate dosage of atropine is not easy to determine; small dosages are not sufficient to achieve the therapeutic effect and large dosages can easily cause poisoning (Sharma et al, 2013). A previous study shows that penehyclidine hydrochloride (PHC) is a new generation cholinergic antagonist (Han et al, 2005) that can selectively act on M1, M3, N1, and N2 receptors, and can rapidly improve the muscarinic symptoms with a little effect on the heart rate.…”
Section: Introductionmentioning
confidence: 99%
“…Although the combination of a cholinesterase reactivator and anticholinergic atropine has a poor effect (Buckley et al, 2011;Elsinghorst et al, 2013), a previous study has shown that use of atropine at an optimum dose can decrease the mortality rate (Biswas et al, 2013). However, atropine has a short half-life, requires administration of large dosages, and patients with severe poisoning require intravenous administration (Abedin et al, 2012); moreover, repeated administration at an interval of 2-10 min is required (Connors et al, 2013) and nursing of patients is tedious; furthermore, an appropriate dosage of atropine is not easy to determine; small dosages are not sufficient to achieve the therapeutic effect and large dosages can easily cause poisoning (Sharma et al, 2013). A previous study shows that penehyclidine hydrochloride (PHC) is a new generation cholinergic antagonist (Han et al, 2005) that can selectively act on M1, M3, N1, and N2 receptors, and can rapidly improve the muscarinic symptoms with a little effect on the heart rate.…”
Section: Introductionmentioning
confidence: 99%
“…Studies conducted after the year of 2000 have consistently shown mortality rates below 15%. 37,39 This can be explained by universal provision of continuous high dose atropine, consistent use of pralidoxime and better access to supportive therapy such as ICU care, ventilator support and respiratory therapy etc. In our study, the mortality was 17.34% (56 of the 323 cases) and 124 (38.41%) patients had to be ventilated.…”
mentioning
confidence: 99%
“…Once atropinization has been obtained, an infusion should be set up and titrated against effect. This doubling-dose approach has been shown in a randomized controlled trial to markedly speed resuscitation (from a mean of 152 to 24 min) and reduce mortality (from 22.5 to 8%) compared with standard atropine dosing (2-5 mg every 10-15 min) (94). No clinical studies have been performed after OP nerve agent poisoning, but this titrated regimen can be followed for patients who survive to hospital presentation (95).…”
Section: Management Of Op Nerve Agent and Insecticide Poisoningmentioning
confidence: 99%